Viridian Therapeutics, Inc. (VRDN)
29.58
+0.33
(+1.13%)
USD |
NASDAQ |
Feb 09, 16:00
29.58
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics Accounts Payable (Quarterly) : 10.06M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 0.951M |
| ADMA Biologics, Inc. | 24.02M |
| Avantor, Inc. | 691.60M |
| Immunovant, Inc. | 8.616M |
| Plus Therapeutics, Inc. | 11.62M |